Cytiva and LevitasBio join forces to transform single-cell workflow and accelerate therapeutic development
February 6, 2024
- Technologies work together to simplify single-cell workflows, saving time for academic researchers.
- Combined VIA Extractor and LeviCell system addresses key challenges in sample preparation, minimizing single-cell damage and stress.
Two leading life sciences companies, Cytiva and LevitasBio, are collaborating to deliver an innovative single-cell workflow for genomics researchers in academia and industry. This collaboration marks a significant milestone in improving how samples are prepared, enabling researchers to more quickly perform tasks like breaking down tissues and purifying individual cell suspensions for single-cell analysis and other downstream applications. This is particularly important for advancing personalized medicine by providing insights into disease mechanisms and therapeutic targets, supporting oncology research, and accelerating scientific discovery.
Stephen Bell, President, Discovery & Medical, Cytiva, says: "Our collaboration is rooted in the shared goal of enabling breakthrough discoveries in Life Sciences research that advance and accelerate therapeutic developments. By combining the strengths of our products with LevitasBio, we aim to empower researchers with a more efficient and gentle approach to sample preparation."
Single-cell analysis plays a pivotal role in advancing therapeutic approaches, particularly in cancer research. Cytiva’s and LevitasBio’s expertise and technologies will be used to create a streamlined, semi-automated workflow solution. This will reduce single-cell damage or stress and improve overall single-cell health—all critical elements for producing viable samples for use in subsequent stages of genetic studies or other downstream cell-based assays.
Martin Pieprzyk, CEO, LevitasBio, says: "The VIA Extractor and LeviCell platform offers a more complete approach to tissue dissociation and single-cell suspension cleanup, which better enables researchers to develop innovative solutions in the personalized medicine space. Through this pioneering effort, we’re taking a significant step towards facilitating breakthroughs in research and translational applications, aligning with our commitment to driving innovation in the life sciences industry."
The key technologies at the forefront of this collaboration are the VIA Extractor from Cytiva and the LeviCell 1.0 and LeviCell EOS systems from LevitasBio. See the products in action: VIA Extractor | LeviCell EOS system
Trademark statement: VIA Extractor is a trademark of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva. © 2020-2024 Cytiva.
About Cytiva
At Cytiva, our mission is to advance and accelerate the development of therapeutics. With nearly 15 000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers. Learn more at cytiva.com.
About LevitasBio
At LevitasBio, our mission is to drive scientific progress and enhance human health through cutting-edge techniques in sample preparation and cellular analysis. Our exclusive label-free Levitation Technology represents a transformative breakthrough, preserving native cellular states, ensuring sample quality, and empowering researchers. We redefine research with a new standard, pioneering new discoveries across scientific disciplines. Join us on this journey to advance science and elevate human well-being.
Media contact Cytiva:
James McGarry
[email protected]
Media contact LevitasBio:
Melissa Ma
[email protected]